• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number RLT261416
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/01/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient medications: aspirin, vit d, flonase, probiotics, synthroid, cortisone, percocet.Additional devices implanted and/or related to this event: plc141200/20302006, udi (b)(4).The review of the manufacturing paperwork verified that these lot met all pre-release specifications.
 
Event or Problem Description
On (b)(6) 2019, the patient was implanted with a gore® excluder® aaa endoprostheses to treat an inflammatory aorta complicated by cancer treatment with chemotherapy.The patient tolerated the procedure.It was reported that on (b)(6) 2020, the patient was diagnosed with continued aneurysmal degradation at the proximal end of the graft and in the left common iliac artery.That day the physician placed three cook endovascular cuffs proximally up to the next renal artery along with a gore® excluder® aaa iliac extender endoprosthesis (pll161007 lot #20056981) in the left common iliac artery.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10094560
Report Number3007284313-2020-00135
Device Sequence Number3122339
Product Code MIH
UDI-Device Identifier00733132622467
UDI-Public00733132622467
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/12/2022
Device Model NumberRLT261416
Device Catalogue NumberRLT261416
Device Lot Number21084519
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/27/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age68 YR
Patient Weight74
-
-